Last reviewed · How we verify
Simulated drug of DING KUN DAN
Ding Kun Dan is a traditional Chinese medicine formulation that acts as a hemostatic and anti-inflammatory agent to stop bleeding and reduce inflammation.
Ding Kun Dan is a traditional Chinese medicine formulation that acts as a hemostatic and anti-inflammatory agent to stop bleeding and reduce inflammation. Used for Hemostasis and bleeding control, Inflammatory conditions (traditional use).
At a glance
| Generic name | Simulated drug of DING KUN DAN |
|---|---|
| Sponsor | Peking Union Medical College Hospital |
| Modality | Small molecule |
| Therapeutic area | Hematology / Traditional Medicine |
| Phase | FDA-approved |
Mechanism of action
This herbal compound works through multiple pathways typical of traditional Chinese medicine, including promoting blood stasis resolution, reducing inflammation, and enhancing local hemostasis. The exact molecular mechanisms are not well-characterized in modern pharmacological terms, as the drug is a complex botanical mixture rather than a single-target agent.
Approved indications
- Hemostasis and bleeding control
- Inflammatory conditions (traditional use)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Simulated drug of DING KUN DAN CI brief — competitive landscape report
- Simulated drug of DING KUN DAN updates RSS · CI watch RSS
- Peking Union Medical College Hospital portfolio CI